A clinical study with noninvasive positive pressure ventilation on chronic obstructive pulmonary disease with type Ⅱ respiratory failure
10.3760/cma.j.issn.1673-4904.2009.15.009
- VernacularTitle:无创正压通气治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的临床研究
- Author:
Zhanxiang LIU
;
Xiuli ZHANG
;
Anmeng WEI
;
Yanli LI
;
Ce SHI
;
Yanhong LIU
- Publication Type:Journal Article
- Keywords:
Chronic obstructive pulmonary disease;
Noninvasive positive pressure ventilation;
Respiratory failure
- From:
Chinese Journal of Postgraduates of Medicine
2009;32(15):22-24
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of noninvasive positive pressure ventilation (NIPPV)on chronic obstructive pulmonary disease (COPD) with type Ⅱ respiratory failure. Methods Seventy-six cases of COPD with type Ⅱ respiratory failure were randomly divided into two groups.All patients were treated with antibiotics and other coventional therapy, 6 hours of intravenous drop infusion coramine was added to the control group (38 cases) and 6 hours of NIPPV was added to the treatment group (38 cases). Vital signs and arterial blood gas analysis were evaluated. Results After 6 hours of treatment, blood pressure, heart rate, respiratory rate and pH were significantly improved in the treatment group than those in the control group (P< 0.05 or < 0.01).Compared with the control group, there was a significant improvement of pH in the treatment group (P < 0.05). PaO2 increased [(81.7 ± 6.3) mm Hg (1 mm Hg = 0.133 kPa) vs (50.6 ± 4.3) mm Hg, (67.6 ± 7.4) mm Hg vs (50.8 ± 5.2) mm Hg] and PaCO2 decreased [(49.6 ± 4.5) mm Hg vs (78.5 ± 10.4) mm Hg, (60.8 ± 6.1)mm Hg vs (76.8 ± 8.3) mm Hg] was found in both groups, the amplitudes of PaO2 and PaCO2 before and after treatment were more singnificant in the treatment group (P < 0.01). Conclusion NIPPV on COPD with type Ⅱ respiratory failure can improve clinical symptom and arterial blood gas analysis more significantly than conventional therapy.
